After endorsing her vaccine advisory committee’s recommendations on COVID-19 booster shots, CDC director Rochelle P. Walensky, MD, MPH, added a recommendation of her own. It was the top story in infectious disease last week.
Other top stories included data on a second dose of Johnson & Johnson’s COVID-19 vaccine and new evidence of resistance to malaria treatment in Africa.
Read these and more top stories in infectious disease below:
In ‘scientific close call,’ CDC director adds booster recommendation for HCWs
CDC Director Rochelle P. Walensky, MD, MPH, issued a statement late Thursday night endorsing her vaccine advisory committee’s recommendations — made earlier in the day — on which Americans should be eligible for COVID-19 booster shots. Read more.
J&J reports second dose of COVID-19 vaccine boosts protection to 94%
A second dose of Johnson & Johnson’s COVID-19 vaccine given 2 months after the initial shot boosted protection to 94% among people enrolled in a phase 3 trial in the United States, the company said Tuesday. Read more.
Resistant malaria ‘has gained a foothold in Africa’
Researchers identified Plasmodium falciparum that is resistant to artemisinin — the main component of first-line treatments for malaria in endemic areas — among a small group of patients in northern Uganda. Read more.
‘We must redouble our efforts’: More signs HCV care has suffered during pandemic
Because of pandemic-related disruptions in hepatitis C care, researchers said thousands of cases will remain unidentified with fewer patients initiating care and achieving SVR. Read more.
Pfizer vaccine elicits lower antibody levels in older adults
The Pfizer-BioNTech COVID-19 vaccine elicited “relatively lower” antibody levels in adults aged 50 years or older than in adults aged younger than 50 years, researchers reported in JAMA Network Open. Read more.
Get the latest news and education delivered to your inbox
© 2021 Healio All Rights Reserved.
Get the latest news and education delivered to your inbox
© 2021 Healio All Rights Reserved.